Death, that inescapable certainty that makes us all equal, seems to be a concept that does not quite have a place in the minds of some billionaires. For them, possessors of fortunes that defy the imagination, the idea of aging and eventually dying becomes a bitter taste, an intolerable barrier on their path to accumulation and unlimited enjoyment.
This desire to transcend the barrier of mortality has driven a booming industry: the search for longevity. It is not just about living longer, but doing so with quality, avoiding the diseases and deterioration that accompany the passage of time.
And who better to finance this crusade than those with the resources to make it a reality. Figures such as Larry Page, co-founder of Google, or Jeff Bezos, founder of Amazon, have poured part of their fortunes into companies dedicated to the research and development of technologies that promise to prolong human life.
But investment is just the tip of the iceberg. Many of these tycoons personally undergo experimental treatments, becoming guinea pigs in their own crusade against aging.
One of the most striking cases is that of Peter Diamandis, a fervent advocate of radical life extension. This engineer and entrepreneur, known for creating the X Prize, offers $101 million to anyone who can reverse human aging by 20 years. His commitment to the cause is such that he himself follows a rigorous anti-aging regimen that includes periodic plasma transfusions, a daily cocktail of 70 pills and constant analysis of his bodily functions, including daily analysis of his feces.
This extravagant (for some) lifestyle costs him more than $120,000 a year on health, a negligible figure for someone with a fortune in the order of a billion.
Diamandis' case, although extreme, reflects a growing trend among the elite. The quest for longevity has become a multi-billion dollar industry, with companies offering everything from gene therapies to dietary supplements that promise to turn back the biological clock.
However, this quest for immortality is not without controversy. Many critics question the ethics of this research, arguing that it only benefits the wealthy elite while millions of people around the world lack access to basic health services.
In addition, there is debate about the social implications of increased longevity. What would happen to overpopulation, resource distribution, and social structure if life expectancy were significantly extended?
Despite the unknowns and ethical dilemmas, the quest for longevity is advancing by leaps and bounds, driven by wealth and the human desire to challenge the limits of nature. Only time will tell whether this crusade will achieve its ultimate goal: defeating death or at least delaying it long enough to enjoy an extraordinarily long life.
Meanwhile, the gap between those who dream of immortality and those who struggle to survive another day widens, raising questions about fairness and justice in a world where delaying one's own death could become a luxury reserved for a privileged few.
As my grandfather said: How unfair the world is, some with so much and others with so little!!!
EN 
ES